Is a complete CNTB research report available?

No complete published report is available for Connect Biopharma Holdings Limited (CNTB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Connect Biopharma Holdings Limited (CNTB)

NASDAQ: CNTB · USD

$0.85

+0.01 (+0.8%)· Recorded snapshot

Market cap	53.5M
Revenue (ttm)	3M
Net income (ttm)	-69M
EPS (ttm)	-$1.19
Shares out	63M
Volume	337,397
Beta	-0.18

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3M
Net income (ttm): -69M
EPS (ttm): -$1.19
Market cap: 53.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Metric	Value
Amount currency	USD
CIK code	0001835268
Company name	Connect Biopharma Holdings Limited
Country	United States
Country code	US
CUSIP number	G23549101
Earnings date	2026-11-11
Earnings time	bmo
Employees	64
Employees change	2
Employees growth	3.23%
Enterprise value	$22.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2012
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2021-03-19
Is primary listing	Yes
Is SPAC	No
ISIN number	KYG235491019
Last 10-K release date	2026-03-31
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$53.5M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$0.85
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CNTB
U.S. state	California
Website	https://www.connectbiopharm.com

Metric

Value

Amount currency

USD

CIK code

0001835268

Company name

Connect Biopharma Holdings Limited

Country

United States

Country code

CUSIP number

G23549101

Earnings date

2026-11-11

Earnings time

bmo

Employees

Employees change

Employees growth

3.23%

Enterprise value

$22.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2012

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2021-03-19

Is primary listing

Yes

Is SPAC

ISIN number

KYG235491019

Last 10-K release date

2026-03-31

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$53.5M

Market cap category

Micro-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$0.85

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

CNTB

U.S. state

California

Website

https://www.connectbiopharm.com

Metric	Value
Earnings yield	-140.49%
EV/Sales	7.29x
FCF / EV yield	-281.71%
FCF yield	-115.68%
Forward EV/Sales	2.78x
Forward P/S	6.76x
P/B ratio	1.98x
P/S ratio	17.75x
Price / tangible book value	1.95x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-140.49%

EV/Sales

7.29x

FCF / EV yield

-281.71%

FCF yield

-115.68%

Forward EV/Sales

2.78x

Forward P/S

6.76x

P/B ratio

1.98x

P/S ratio

17.75x

Price / tangible book value

1.95x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	100%
Operating margin	-2,384.49%
Pretax margin	-2,329.66%
Profit per employee	$-1.1M
Revenue per employee	$46,141
ROA	-69.75%
ROA (5Y)	-28.6%
ROCE	-259.15%
ROE	-140.51%
ROE (5Y)	-113.3%
ROIC	-88.31%
SBC / revenue	145.38%
Tax / revenue	6.64%

Metric

Value

Gross margin

100%

Operating margin

-2,384.49%

Pretax margin

-2,329.66%

Profit per employee

$-1.1M

Revenue per employee

$46,141

ROA

-69.75%

ROA (5Y)

-28.6%

ROCE

-259.15%

ROE

-140.51%

ROE (5Y)

-113.3%

ROIC

-88.31%

SBC / revenue

145.38%

Tax / revenue

6.64%

Metric	Value
EPS growth years	0
Gross profit growth	50.28%
Gross profit growth (Q)	5,666.67%
Net income growth years	0
Revenue growth	50.28%
Revenue growth (Q)	5,666.67%
Revenue growth (QoQ)	1,537.87%
Revenue growth quarters	1
Revenue growth years	0

Metric

Value

EPS growth years

Gross profit growth

50.28%

Gross profit growth (Q)

5,666.67%

Net income growth years

Revenue growth

50.28%

Revenue growth (Q)

5,666.67%

Revenue growth (QoQ)

1,537.87%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-50,000
Depreciation and amortization	$685,000
EBIT	$-70.4M
EBITDA	$-69.7M
EPS	$-1.19
FCF per share	$-0.96
Financing cash flow	$19.9M
Free cash flow	$-60.6M
Free cash flow minus SBC	$-64.9M
Gross profit	$3M
Income taxes	$196,000
Investing cash flow	$26.9M
Net cash flow	$-13.6M
Net income	$-69M
Operating cash flow minus SBC	$-64.9M
Operating income	$-70.4M
Revenue	$3M
Stock-based compensation	$4.3M

Metric

Value

Capital expenditures

$-50,000

Depreciation and amortization

$685,000

EBIT

$-70.4M

EBITDA

$-69.7M

EPS

$-1.19

FCF per share

$-0.96

Financing cash flow

$19.9M

Free cash flow

$-60.6M

Free cash flow minus SBC

$-64.9M

Gross profit

$3M

Income taxes

$196,000

Investing cash flow

$26.9M

Net cash flow

$-13.6M

Net income

$-69M

Operating cash flow minus SBC

$-64.9M

Operating income

$-70.4M

Revenue

$3M

Stock-based compensation

$4.3M

Metric	Value
Altman Z-Score	-13.9
Book value per share	$0.43
Debt / equity	0.02
Long-term assets	$4.8M
Long-term liabilities	$310,000
Net cash (debt)	$30.9M
Net cash / market cap	58.94%
Net cash growth	-56.43%
Net debt / equity	-1.15
Piotroski F-Score	2
Property, plant and equipment	$4.2M
Shareholders' equity	$26.9M
Tangible book value	$26.8M
Tangible book value per share	$0.43
Total assets	$43.5M
Total cash	$31.5M
Total debt	$596,000
Total liabilities	$16.6M
WACC	3.21%

Metric

Value

Altman Z-Score

-13.9

Book value per share

$0.43

Debt / equity

0.02

Long-term assets

$4.8M

Long-term liabilities

$310,000

Net cash (debt)

$30.9M

Net cash / market cap

58.94%

Net cash growth

-56.43%

Net debt / equity

-1.15

Piotroski F-Score

Property, plant and equipment

$4.2M

Shareholders' equity

$26.9M

Tangible book value

$26.8M

Tangible book value per share

$0.43

Total assets

$43.5M

Total cash

$31.5M

Total debt

$596,000

Total liabilities

$16.6M

WACC

3.21%

Metric	Value
Asset turnover	0.05
Current assets	$38.6M
Current liabilities	$16.3M
Current ratio	2.37
Net working capital	$-8.8M
Quick ratio	2.11
Working capital	$22.3M
Working capital turnover	0.07

Metric

Value

Asset turnover

0.05

Current assets

$38.6M

Current liabilities

$16.3M

Current ratio

2.37

Net working capital

$-8.8M

Quick ratio

2.11

Working capital

$22.3M

Working capital turnover

0.07

Metric	Value
Buyback yield / dilution	-4.44%
Dividend yield	0%
Shareholder yield	-4.44%

Metric

Value

Buyback yield / dilution

-4.44%

Dividend yield

Shareholder yield

-4.44%

Metric	Value
150-day SMA	$2.08
1D price change	0.82%
1M price change	-21.31%
1M total return	-21.31%
1W price change	-2.9%
1W total return	-2.9%
1Y price change	-46.89%
1Y return CAGR	-46.91%
1Y total return	-46.89%
20-day SMA	$0.88
200-day SMA	$2.21
3M price change	-59.53%
3M total return	-59.53%
50-day SMA	$1.42
50-day SMA vs 200-day SMA	50under200
52-week high	$3.82
52-week high date	2026-03-27
52-week low	$0.73
52-week low date	2026-10-22
6M price change	-65.31%
6M total return	-65.31%
All-time high	$3.82
All-time high date	2026-03-27
All-time low	$0.73
All-time low date	2026-10-22
Average true range (ATR)	$0.11
Average volume	1.6M
Beta (1Y)	-1.37
Beta (2Y)	-1.85
Beta (5Y)	-0.18
Change from 52-week high	-77.76%
Change from 52-week low	16.05%
Change from all-time high	-77.75%
Change from all-time low	16.11%
Change from open	2.58%
Day's gap	-1.72%
Dollar volume	$286,585
High price	$0.85
Low price	$0.83
Monthly RSI	0
Open price	$0.83
Position in 52-week range	97.99%
Premarket change	0.88%
Premarket close	$0.84
Premarket price	$0.85
Premarket volume	2.8K
Previous close	$0.84
Price vs 150-day SMA	-59.05%
Price vs 20-day SMA	-3.4%
Price vs 200-day SMA	-61.51%
Price vs 50-day SMA	-40.2%
Relative volume	0.21
Return from IPO price	-95.1%
RSI	35.88
Sharpe ratio	-0.14
Sortino ratio	-0.15
Volume	337.4K
Weekly RSI	32.44
YTD price change	-69.87%
YTD total return	-69.87%

Metric

Value

150-day SMA

$2.08

1D price change

0.82%

1M price change

-21.31%

1M total return

-21.31%

1W price change

-2.9%

1W total return

-2.9%

1Y price change

-46.89%

1Y return CAGR

-46.91%

1Y total return

-46.89%

20-day SMA

$0.88

200-day SMA

$2.21

3M price change

-59.53%

3M total return

-59.53%

50-day SMA

$1.42

50-day SMA vs 200-day SMA

50under200

52-week high

$3.82

52-week high date

2026-03-27

52-week low

$0.73

52-week low date

2026-10-22

6M price change

-65.31%

6M total return

-65.31%

All-time high

$3.82

All-time high date

2026-03-27

All-time low

$0.73

All-time low date

2026-10-22

Average true range (ATR)

$0.11

Average volume

1.6M

Beta (1Y)

-1.37

Beta (2Y)

-1.85

Beta (5Y)

-0.18

Change from 52-week high

-77.76%

Change from 52-week low

16.05%

Change from all-time high

-77.75%

Change from all-time low

16.11%

Change from open

2.58%

Day's gap

-1.72%

Dollar volume

$286,585

High price

$0.85

Low price

$0.83

Monthly RSI

Open price

$0.83

Position in 52-week range

97.99%

Premarket change

0.88%

Premarket close

$0.84

Premarket price

$0.85

Premarket volume

2.8K

Previous close

$0.84

Price vs 150-day SMA

-59.05%

Price vs 20-day SMA

-3.4%

Price vs 200-day SMA

-61.51%

Price vs 50-day SMA

-40.2%

Relative volume

0.21

Return from IPO price

-95.1%

RSI

35.88

Sharpe ratio

-0.14

Sortino ratio

-0.15

Volume

337.4K

Weekly RSI

32.44

YTD price change

-69.87%

YTD total return

-69.87%

Metric	Value
Float	17.3M
Float percentage	27.48%
Shares change (QoQ)	11.21%
Shares change (YoY)	4.44%
Shares held by insiders	15.19%
Shares held by institutions	19.33%
Shares outstanding	63M
Short % of shares	7.88%
Short ratio	0.4 days

Metric

Value

Float

17.3M

Float percentage

27.48%

Shares change (QoQ)

11.21%

Shares change (YoY)

4.44%

Shares held by insiders

15.19%

Shares held by institutions

19.33%

Shares outstanding

63M

Short % of shares

7.88%

Short ratio

0.4 days

Connect Biopharma Holdings Limited (CNTB)

Price

Financial snapshot

Fair-value bridge

Latest news · CNTB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CNTB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CNTB

Frequently asked questions